VTYX

Ventyx Biosciences Inc

NASDAQ: VTYX · HEALTHCARE · BIOTECHNOLOGY

$14.00

+0.00% today

Updated 2026-03-04

Market cap

$1.00B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.49

Dividend yield

—

52W range

$1 – $15

Volume

4.1M

Market cap

$1.00B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.49

Dividend yield

—

52W range

$1 – $15

Volume

4.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target

$13.00

-7.14%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy0 Buy8 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-17.56M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-83.75M	$-108.43M	$-192.96M	$-135.12M	$-22.83M
EPS	—	—	—	—	$-1.49
Free cash flow	$-38.91M	$-99.05M	$-167.04M	$-131.11M	$-17.56M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VTYX	$1.00B	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Ventyx Biosciences Inc trades at $14.00. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Ventyx Biosciences Inc's stock price?

Ventyx Biosciences Inc (VTYX) trades at $14.00.

Is Ventyx Biosciences Inc overvalued?

Ventyx Biosciences Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Ventyx Biosciences Inc (VTYX)?

The 12-month analyst consensus target is $13.00, about 7.1% below the current $14.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-0.45%

Beta1.27

50D MA$13.23

200D MA$6.78

Shares out0.07B

Float0.05B

Short ratio—

Avg volume4.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VTYX vs LLY →VTYX vs JNJ →VTYX vs ABBV →Stock screener →